The $2 billion UCB facility at Rowen is projected to generate approximately $5 billion in total economic impact, create 330+ permanent jobs and 1,000+ construction jobs and mark UCB's first-ever U.S. pharmaceutical biologics manufacturing site — positioning Georgia as a national leader in life sciences manufacturing.

(Gwinnett County, Ga., March 24, 2026) – Gwinnett County officials proudly announce that UCB, a global biopharmaceutical company headquartered in Brussels, Belgium, will build its first U.S. pharmaceutical biologics manufacturing facility at Rowen, a 2,000-acre innovation and knowledge community in Gwinnett County, Georgia.

The $2 billion capital investment is the largest in Gwinnett County's history and is projected to generate approximately $5 billion in total economic impact.

UCB focuses on developing medicines for people living with severe neurological and autoimmune conditions. The 460,000-square-foot facility, which will be located on approximately 79 acres within the Rowen community, brings advanced manufacturing onshore. It will feature a state-of-the-art, digital-first manufacturing approach leveraging artificial intelligence, robotics and advanced automation while prioritizing efficient use of natural resources.

“We are thrilled that UCB has chosen Gwinnett County as its first-ever site in the U.S. to pioneer innovation and advance its global operations,” said Chairwoman Nicole Love Hendrickson, Gwinnett County Board of Commissioners. “This long-term investment reflects the collective vision we set in motion to establish Rowen, supported by the stability of our local government and our consistent approach to economic development. Gwinnett County offers a highly skilled workforce, world-class infrastructure and a quality of life that supports long-term success.”

UCB’s selection of Rowen represents a catalytic milestone for Gwinnett County and signals that the County’s long-term economic development strategy is delivering meaningful results. The project will create more than 330 permanent roles with average annual salaries exceeding $72,000, in addition to more than 1,000 construction jobs, and further strengthen Gwinnett County’s position as a destination for discovery, collaboration and sustained economic growth.

Gwinnett County has committed to incentives valued at more than $174 million comprised of property tax savings, fee waivers and infrastructure investment to support the project.

“This investment represents a significant step forward for Gwinnett County and for the residents of District 3,” said District 3 Commissioner Jasper Watkins III. “As a healthcare professional, I understand the importance of advancing life sciences and strengthening our nation’s pharmaceutical capabilities. UCB choosing Rowen reflects the strength of our community, our workforce and our commitment to building a future centered on innovation, opportunity and improved health outcomes.”

Since announcing Rowen in 2020, Gwinnett County has made strategic investments to transform the site into a 2,000-acre knowledge community designed to bring together research, industry and talent to create a destination for top global companies. Initial development on the Rowen property began following a nearly $70 million investment from the Development Authority of Gwinnett County, supporting land acquisition and early infrastructure buildout for the project. Rowen completed its first phase of roads and utilities in 2025 and is set to start construction on its Convergence Center this summer. More than 1,900 acres remain available at Rowen for additional companies and long-term expansion.

As Rowen continues to take shape, today’s announcement sends a clear message to companies around the world: Gwinnett County is committed to providing the services, infrastructure and quality of life that leading organizations are seeking as they grow and innovate.

MORE ABOUT UCB’S INVESTMENT IN GWINNETT COUNTY

What is UCB's new facility in Gwinnett County, Georgia?
UCB, a global biopharmaceutical company headquartered in Brussels, Belgium, is building a 460,000-square-foot biologics manufacturing facility at Rowen in Gwinnett County, Georgia. It is UCB's first pharmaceutical biologics manufacturing site in the United States, representing a $2 billion capital investment.

How many jobs will UCB create in Gwinnett County?
UCB's Rowen facility will create more than 330 permanent life sciences jobs and over 1,000 construction jobs in Gwinnett County, Georgia.

What is the economic impact of UCB's investment in Gwinnett County?
At a planned $2 billion investment, UCB’s project represents the largest capital investment in 
Gwinnett County’s history. Today, the site generates no revenue — this investment transforms it into a long-term source of jobs, business activity and local revenue, ultimately generating an estimated $5 billion in economic impact for Gwinnett County and the greater Atlanta metropolitan area.
 
What is Rowen in Gwinnett County, Georgia?
Rowen is a 2,000-acre innovation and knowledge community located in Gwinnett County, Georgia, designed to attract life sciences, technology and research organizations to the Atlanta metropolitan region. More than 1,900 acres remain available at Rowen to support additional companies and long-term expansion as the site evolves into a destination for advanced research and development, clean manufacturing and innovation.
 
What medicines does UCB manufacture?
UCB develops and manufactures medicines for people living with severe neurological and autoimmune conditions.